Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Benatar

Showing results (211-220 of 242) with videos related to

Pageof 25
Sort By:
The Lancet. Neurology|October 18, 2024
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trialJan C Koch, Andreas Leha, Helen Bidner, et al.
Neurology|December 3, 2021
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG StudyRichard J Nowak, Christopher S Coffey, Jonathan M Goldstein, et al.
Neurology. Genetics|June 30, 2017
Abnormal expression of homeobox genes and transthyretin in <i>C9ORF72</i> expansion carriersNiCole A Finch, Xue Wang, Matthew C Baker, et al.
EMBO Molecular Medicine|December 3, 2020
Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosisKaterina Placek, Michael Benatar, Joanne Wuu, et al.
European Journal of Human Genetics : EJHG|February 16, 2025
An observational study of pleiotropy and penetrance of amyotrophic lateral sclerosis associated with CAG-repeat expansion of ATXN2Koen C Demaegd, Aoife Kernan, Johnathan Cooper-Knock, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 10, 2023
Clinical testing panels for ALS: global distribution, consistency, and challengesAllison A Dilliott, Ahmad Al Nasser, Marwa Elnagheeb, et al.
Neuron|December 15, 2010
Exome sequencing reveals VCP mutations as a cause of familial ALSJanel O Johnson, Jessica Mandrioli, Michael Benatar, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Identification of a presymptomatic and early disease signature for Amyotrophic Lateral Sclerosis (ALS): protocol of the premodiALS studyLaura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Nature Neuroscience|November 27, 2019
Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock proteinSali M K Farhan, Daniel P Howrigan, Liam E Abbott, et al.
Neurology|January 23, 2015
Novel mutations expand the clinical spectrum of DYNC1H1-associated spinal muscular atrophyMariacristina Scoto, Alexander M Rossor, Matthew B Harms, et al.
Pageof 25

Showing results (211-220 of 242) with videos related to

Sort By:
Pageof 25
The Lancet. Neurology|October 18, 2024
Safety, tolerability, and efficacy of fasudil in amyotrophic lateral sclerosis (ROCK-ALS): a phase 2, randomised, double-blind, placebo-controlled trialJan C Koch, Andreas Leha, Helen Bidner, et al.
Neurology|December 3, 2021
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG StudyRichard J Nowak, Christopher S Coffey, Jonathan M Goldstein, et al.
Neurology. Genetics|June 30, 2017
Abnormal expression of homeobox genes and transthyretin in <i>C9ORF72</i> expansion carriersNiCole A Finch, Xue Wang, Matthew C Baker, et al.
EMBO Molecular Medicine|December 3, 2020
Machine learning suggests polygenic risk for cognitive dysfunction in amyotrophic lateral sclerosisKaterina Placek, Michael Benatar, Joanne Wuu, et al.
European Journal of Human Genetics : EJHG|February 16, 2025
An observational study of pleiotropy and penetrance of amyotrophic lateral sclerosis associated with CAG-repeat expansion of ATXN2Koen C Demaegd, Aoife Kernan, Johnathan Cooper-Knock, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 10, 2023
Clinical testing panels for ALS: global distribution, consistency, and challengesAllison A Dilliott, Ahmad Al Nasser, Marwa Elnagheeb, et al.
Neuron|December 15, 2010
Exome sequencing reveals VCP mutations as a cause of familial ALSJanel O Johnson, Jessica Mandrioli, Michael Benatar, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Identification of a presymptomatic and early disease signature for Amyotrophic Lateral Sclerosis (ALS): protocol of the premodiALS studyLaura Tzeplaeff, Ana Galhoz, Clara Meijs, et al.
Nature Neuroscience|November 27, 2019
Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock proteinSali M K Farhan, Daniel P Howrigan, Liam E Abbott, et al.
Neurology|January 23, 2015
Novel mutations expand the clinical spectrum of DYNC1H1-associated spinal muscular atrophyMariacristina Scoto, Alexander M Rossor, Matthew B Harms, et al.
Pageof 25